Jack V Greiner Selected Research

Olopatadine Hydrochloride (Patanol)

1/2013	A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model.
1/2011	Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.
6/2007	Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
5/2005	A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
12/2004	Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack V Greiner Research Topics

Disease

7	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020 - 10/2002
7	Pruritus (Itching) 01/2013 - 07/2002
6	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2013 - 07/2002
2	COVID-19 01/2021 - 10/2020
2	Hypersensitivity (Allergy) 05/2005 - 07/2003
1	Dehydration (Water Stress) 01/2022
1	Diabetic Foot 01/2022
1	Juvenile Epithelial of Meesmann Corneal Dystrophy 12/2017
1	Edema (Dropsy) 07/2007
1	Hyperemia 12/2004
1	Refractive Errors (Refractive Error) 01/2004
1	Meibomian Gland Dysfunction 04/2003

Drug/Important Bio-Agent (IBA)

8	Ophthalmic Solutions (Eye Drops)IBA 01/2013 - 07/2002
7	AllergensIBA 01/2013 - 07/2002
5	LipidsIBA 01/2020 - 04/2003
5	Olopatadine Hydrochloride (Patanol)FDA Link 01/2013 - 12/2004
3	Lubricant Eye Drops (Artificial Tears)IBA 01/2020 - 07/2003
3	Ketotifen (Ketotifene)FDA Link 12/2003 - 07/2002
2	alcaftadine FDA Link 01/2013 - 01/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 04/2010 - 01/2005
2	Mast Cell StabilizersIBA 06/2007 - 05/2005
2	Histamine Antagonists (Antihistamines)IBA 06/2007 - 05/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	EmulsionsIBA 01/2022
1	HydrocarbonsIBA 01/2022
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 01/2022
1	MineralsIBA 01/2022
1	Petrolatum (Vaseline)FDA Link 01/2022
1	epinastine FDA Link 06/2007
1	Pheniramine (Pheniramine Maleate)FDA Link 05/2005
1	Naphazoline (All Clear)FDA LinkGeneric 05/2005
1	Vasoconstrictor AgentsIBA 05/2005
1	Rose BengalIBA 01/2005
1	Coloring Agents (Dyes)IBA 01/2005
1	levocabastine (Bilina)FDA Link 12/2004
1	Pharmaceutical PreparationsIBA 12/2004
1	AntigensIBA 12/2003
1	Nedocromil (Alocril)FDA Link 07/2003
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2002
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 07/2002

Therapy/Procedure

2	Therapeutics 07/2007 - 04/2003
2	Contact Lenses 01/2004 - 10/2002
1	Skin Cream 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021
1	Photochemotherapy (Photodynamic Therapy) 10/2020
1	Photorefractive Keratectomy 12/2017